Compare Indivior Pharmaceuticals Inc. Common Stock (INDV) vs Kimco Realty Corporation (HC) Common Stock (KIM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Indivior Pharmaceuticals Inc. Common Stock vs Kimco Realty Corporation (HC) Common Stock — how do they compare? Indivior Pharmaceuticals Inc. Common Stock trades at $34.3 (market cap $4.18B), while Kimco Realty Corporation (HC) Common Stock trades at $22.48 (market cap $15.06B). The key difference: Kimco Realty Corporation (HC) Common Stock is far larger — about 3.6× Indivior Pharmaceuticals Inc. Common Stock's market cap, and Kimco Realty Corporation (HC) Common Stock pays a 4.99% dividend while Indivior Pharmaceuticals Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Indivior Pharmaceuticals Inc. Common Stock for 0 Days and Kimco Realty Corporation (HC) Common Stock for 6 Days on average.
| INDV | KIM | |
|---|---|---|
Market Cap | $4.18B | $15.06B |
Volume | 1,819,746 | 6,246,987 |
Sector | Health | Real Estate |
52-Week High | $41.83 | $26.38 |
52-Week Low | $24.09 | $19.78 |
Typical Hold Time | 0 Days | 6 Days |
Enterprise Value | $4.47B | $23.22B |
Dividend Yield | — | 4.99% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
KIM trades at $22.45, up 0.58% today, with a bearish technical signal from moving averages but neutral oscillators. The company reported strong earnings beats in recent quarters, with Q3 2026 results expected soon. Fundamentals show robust profitability with a 27.76% net income margin and a P/E of 26.1. Analyst consensus is a Buy with a $26.09 price target, though technical indicators suggest near-term caution.
The outlook for KIM is mixed; strong fundamentals and positive analyst sentiment support upside, but technical bearishness and macroeconomic risks pose challenges. Investment opportunity lies in its high dividend yield and earnings growth, while risks include market volatility and real estate sector headwinds. The stock's performance will hinge on upcoming earnings and broader economic conditions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Indivior Pharmaceuticals Inc. Common Stock
Indivior Pharmaceuticals, Inc. is a pharmaceutical company focused on treatments for opioid use disorder and other addiction-related conditions, including its Suboxone film and tablet products.
Read more on INDV →About Kimco Realty Corporation (HC) Common Stock
Kimco Realty is a real estate investment trust that owns and operates open-air, grocery-anchored shopping centers and mixed-use properties in the United States.
Read more on KIM →
